Literature DB >> 14245160

SOME BIOCHEMICAL AND PHYSICAL PROPERTIES OF THE HUMAN PERMEABILITY GLOBULINS.

L J KAGEN.   

Abstract

Entities:  

Keywords:  ANGIONEUROTIC EDEMA; BIOLOGICAL ASSAY; BLOOD CHEMICAL ANALYSIS; BLOOD PROTEIN DISORDERS; BLOOD PROTEIN ELECTROPHORESIS; CHROMATOGRAPHY; ESTERASES; KALLIKREIN; KININS; METABOLISM; PEPTIDES; PERMEABILITY GLOBULINS; SERUM GLOBULINS; ULTRACENTRIFUGATION; VASODILATOR AGENTS

Mesh：

Substances：

Year:  1964        PMID： 14245160      PMCID： PMC2093675     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN： 0007-1021


× No keyword cloud information.
  10 in total

1.  Isolation of 2 permeability globulins from human serum.

Authors:  L J KAGEN; J P LEDDY; E L BECKER
Journal:  Nature       Date:  1963-02-16       Impact factor: 49.962

2.  Studies on plasma kallikrein and its relationship to plasmin.

Authors:  M E WEBSTER; J V PIERCE
Journal:  J Pharmacol Exp Ther       Date:  1960-12       Impact factor: 4.030

3.  Actions of pure bradykinin.

Authors:  D F ELLIOTT; E W HORTON; G P LEWIS
Journal:  J Physiol       Date:  1960-10       Impact factor: 5.182

4.  Partial purification of a serum inhibitor of C'1-esterase.

Authors:  J PENSKY; L R LEVY; I H LEPOW
Journal:  J Biol Chem       Date:  1961-06       Impact factor: 5.157

5.  Enzymic nature of the serum globulin permeability factor.

Authors:  E L BECKER; D L WILHELM; A A MILES
Journal:  Nature       Date:  1959-05-02       Impact factor: 49.962

6.  Susceptibility of the guinea pig to pharmacological factors from its own serum.

Authors:  M E MACKAY; A A MILES; M SCHACHTER; D L WILHELM
Journal:  Nature       Date:  1953-10-17       Impact factor: 49.962

7.  The Schultz-Dale technique.

Authors:  E J COULSON
Journal:  J Allergy       Date:  1953-09

8.  Hereditary angioneurotic edema. II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein.

Authors:  N S LANDERMAN; M E WEBSTER; E L BECKER; H E RATCLIFFE
Journal:  J Allergy       Date:  1962 Jul-Aug

9.  Bradykinin.

Authors:  G P LEWIS
Journal:  Nature       Date:  1961-11-18       Impact factor: 49.962

10.  Kallikrein, kallidin, kallikrein inhibitors.

Authors:  E WERLE; I TRAUTSCHOLD
Journal:  Ann N Y Acad Sci       Date:  1963-02-04       Impact factor: 5.691
  10 in total
  12 in total

1.  Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein.

Authors:  R W Colman; L Mattler; S Sherry
Journal:  J Clin Invest       Date:  1969-01       Impact factor: 14.808

2.  Permeability factor and kininogenase in guinea-pig serum fractions.

Authors:  B Mason
Journal:  Br J Exp Pathol       Date:  1972-08

3.  On the endogenous mechanism of kinin release. I. Attempts at discriminating kallikreins.

Authors:  R Jahrreiss; E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

4.  Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation.

Authors:  A D Schreiber; A P Kaplan; K F Austen
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

5.  Separation of kinin-forming factors in human plasma.

Authors:  V Eisen; K L Glanville
Journal:  Br J Exp Pathol       Date:  1969-10

6.  The development of permeability activity by undiluted plasma on exposure to glass.

Authors:  D J McConnell; E L Becker
Journal:  Br J Exp Pathol       Date:  1966-04

7.  C1 inactivator inhibition by plasmin.

Authors:  P C Harpel
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

8.  Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.

Authors:  P C Harpel
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

9.  Permeability-increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization.

Authors:  V H Donaldson; O D Ratnoff; W Dias Da Silva; F S Rosen
Journal:  J Clin Invest       Date:  1969-04       Impact factor: 14.808

10.  Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.

Authors:  P C Harpel
Journal:  J Exp Med       Date:  1970-08-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.